Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion

OBJECTIVE: When considering repetitive transcranial magnetic stimulation (rTMS) for major depressive disorder, clinicians often face a lack of detailed information on potential interactions between rTMS and pharmacotherapy. This is particularly relevant to patients receiving bupropion, a commonly pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobek, Christine E, Blumberger, Daniel M, Downar, Jonathan, Daskalakis, Zafiris J, Vila-Rodriguez, Fidel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670017/
https://www.ncbi.nlm.nih.gov/pubmed/26664122
http://dx.doi.org/10.2147/NDT.S91126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670017/
https://www.ncbi.nlm.nih.gov/pubmed/26664122
http://dx.doi.org/10.2147/NDT.S91126

Ejemplares similares